Francisca Vazquez

Francisca Vazquez is a prominent leader in cancer research, currently serving as the Director of the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard since 2011, where leadership encompasses a significant industry-academic partnership aimed at identifying cancer vulnerabilities. Under Francisca Vazquez's guidance, the lab develops innovative computational and experimental methods to uncover therapeutic targets using extensive datasets. Previously, contributions were made at Dana-Farber Cancer Institute, focusing on molecular mechanisms of chronic diseases and cancer metabolism. In addition to current roles as co-founder and scientific advisor for multiple biotech ventures such as Stealth Biotech Company and Riva Therapeutics, and participation on scientific advisory boards at GSK, Francisca Vazquez continues to significantly influence the landscape of cancer research through partnership initiatives and groundbreaking methodologies in omics and functional genomics. Academic qualifications include a PhD from Universitat de les Illes Balears and post-doctoral fellowship experiences at Harvard Medical School.